Japan

Truqap plus Faslodex approved in Japan for HR +ve breast cancer

Truqap plus Faslodex approved in Japan for HR +ve breast cancer

Truqap plus Faslodex approved in Japan for patients with advanced HR-positive breast cancer AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment of adult patients with unresectable or recurrent PIK3CA, AKT1, or PTEN-altered hormone receptor (HR)-positive, HER2-negative breast cancer following progression after treatment with endocrine therapy. The approval […]

Truqap plus Faslodex approved in Japan for HR +ve breast cancer Read More »

US, Japan Sign Space Collaboration Agreement at NASA Headquarters

US, Japan Sign Space Collaboration Agreement at NASA

During an event hosted by NASA Administrator Bill Nelson and Deputy Administrator Pam Melroy at the agency’s Headquarters in Washington, representatives from the United States and Japan gathered to sign an agreement that builds on a long history of space collaboration exploration between the two nations.  U.S. Secretary of State Antony J. Blinken and Japan’s Minister for

US, Japan Sign Space Collaboration Agreement at NASA Read More »